Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 242Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Perspectives in Clinical Research

Submit your manuscripts

  • Online submission
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review

Submit article online

 

Pubmed

July-September 2022 | Vol 13 | Issue  3 Table ofContents RSS Feed
Editorial
Clinical trial agreements and insurance policies – role of the EC
Ravindra Bhaskar Ghooi
The World Medical Assembly, at its 29th meeting in Tokyo, suggested that “the design and performance of each experimental procedure involving human subjects should be clearly formulated in an ex...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Review Article
Advances in orphan drug development: Time to change the status and stereotype
Sayanta Thakur
Rare diseases remain a challenge for many of the countries in the world. The millions of people collectively suffering from rare diseases, in the context of raging COVID-19 pandemics globally, require...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Opinion
Need for revision: EC process, members' training, and compensation formula in the New Drugs and Clinical Trials Rules 2019
Ravindra Bhaskar Ghooi
The New Drugs and Clinical Trial Rules (NDCTR) came in force in 2019, these brought in some changes, but certain earlier parts, such as Rule 122 DAB, were incorporated unchanged. A few sections of the...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Original Article
Prescription audit of a teaching hospital in South India using World Health Organization core prescribing indicators – A cross-sectional study
R Meenakshi, Nitya Selvaraj, Nishanthi Anandabaskar, Anuranjani Dhamodharan, AK Badrinath, Meher Ali Rajamohammad
Aim: World Health Organization (WHO) core prescribing indicators are highly standardized tools in reliably assessing the essential aspects of drug utilization pattern. It is critical that the r...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Read more articles....